ursodeoxycholic acid has been researched along with Hepatic Veno Occlusive Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 6 (24.00) | 2.80 |
| Authors | Studies |
|---|---|
| Halter, JP; Heim, D; Medinger, M; Passweg, JR; Stutz, L | 1 |
| Barker, JN; Bhatt, V; Castro-Malaspina, H; Cavalier, KE; Chung, D; Dahi, PB; Devlin, SM; Giralt, S; Goldberg, JD; Jakubowski, AA; Kernan, NA; Landau, H; Maloy, M; Palazzo, M; Papadopoulos, EB; Perales, MA; Ponce, DM; Sauter, C; Sola, M; Tamari, R; Young, JW | 1 |
| Björklund, A; El-Serafi, I; Mattsson, J; Remberger, M; Ringdèn, O; Sundin, M; Törlén, J; Winiarski, J | 1 |
| Abdel-Azim, H; Abe, JI; Abraham, S; Angelo, J; Auletta, JJ; Bajwa, R; Chan, S; Choi, SW; Corbacioglu, S; Duncan, C; Harden, A; Kalwak, K; Kebriaei, P; Khazal, S; Kleinschmidt, K; Lehmann, LE; Li, S; Mahadeo, KM; McArthur, J; Moffet, JR; Richardson, PG; Schadler, K; Shoberu, B; Tambaro, FP; Tewari, P; Vittorio, J; Zantek, N | 1 |
| Angeletti, A; Bertaina, A; Bonifazi, F; Botti, S; Busca, A; Carella, AM; Cerretti, R; Ciceri, F; Gargiulo, G; Grassi, A; Gualandi, F; Iori, AP; Irrera, G; Marktel, S; Milone, G; Olivari, D; Pomponio, G; Prete, A; Risitano, AM; Rossetti, G; Santarone, S; Sica, S; Vassallo, E; Zecca, M | 1 |
| Cho, BS; Cho, SG; Eom, KS; Kim, DW; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, GJ; Park, S; Park, SS; Yoon, JH | 1 |
| Alsubait, S; Nassereddine, S; Tabbara, I | 1 |
| Cetin, M; Gökce, M; Kuskonmaz, B; Tuncer, M; Uckan Cetinkaya, D | 1 |
| Chan, GC; Cheuk, DK; Chiang, AK; Ha, SY | 1 |
| Abujazar, H; Al Jefri, AH; Al Rawas, A; Al Zahrani, Z; Al-Ahmari, A; Alhejazi, A; Bazarbachi, A; Bekadja, MA; Ibrahim, A; Lahoucine, M; Ousia, S | 1 |
| Atlas, M; Goyal, M; Lakshminarayanan, S; Lipton, JM; Sahdev, I; Vlachos, A | 1 |
| Hassan, Z | 1 |
| Johnson, DB; Savani, BN | 1 |
| Akiyama, K; Hayashi, M; Ikeda, H; Isoyama, K; Mabuchi, M; Shimizu, T; Toyama, D; Yagawa, A; Yamamoto, S | 1 |
| Eriksson, B; Hägglund, H; Juvonen, E; Parkkali, T; Remberger, M; Remes, K; Ringdén, O; Ruutu, T; Volin, L | 1 |
| Cortes, J; Estey, E; Garcia-Manero, G; Giles, F; Kantarjian, H; Thomas, D | 1 |
| Gondo, H; Harada, M; Hashiguchi, M; Higuchi, M; Imamura, R; Kato, K; Kuroiwa, M; Nagafuji, K; Ogata, H; Okamura, T; Oku, E; Ono, N; Otsubo, K; Sata, M; Seki, R; Shibuya, T; Taniguchi, S; Yakushiji, K; Yoshimoto, K | 1 |
| Allan, DS; Fergusson, D; Huebsch, L; Tay, J; Tinmouth, A | 1 |
| Eisenberg, S | 1 |
| Bearman, SI | 1 |
| Comcowich, SA; Spitzer, TR; Tsunoda, SM | 1 |
| Allerton, JP; Callander, N; Essell, JH; Halvorson, R; Harman, GS; Lew, V; Lewis, SK; Schroeder, MT; Snyder, M; Thompson, JM | 1 |
| Aotsuka, N; Maruta, A; Matsuzaki, M; Nishimura, M; Oh, H; Ohashi, K; Okamoto, S; Saito, K; Sakamaki, H; Takahashi, S; Tanabe, J; Tanaka, T; Watanabe, R; Yonekura, S | 1 |
| Im, YH; Jung, CW; Kang, WK; Kim, HS; Kim, K; Kim, SW; Kim, WS; Lee, H; Lee, MH; Park, CH; Park, K; Park, SH; Yoon, SS | 1 |
| Callander, NS; Clement, DJ; Essell, JH; Halvorson, RD; Harman, GS; Snyder, MJ; Thompson, JM | 1 |
8 review(s) available for ursodeoxycholic acid and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement.
Topics: Adolescent; Bilirubin; Biomarkers; Child; Cholagogues and Choleretics; Female; Fibrinolytic Agents; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Polydeoxyribonucleotides; Risk Factors; Severity of Illness Index; Ultrasonography, Doppler; Ursodeoxycholic Acid; Young Adult | 2020 |
Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group.
Topics: Consensus; Evidence-Based Medicine; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Polydeoxyribonucleotides; Predictive Value of Tests; Risk Assessment; Risk Factors; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2021 |
Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
Topics: Anticoagulants; Biomarkers; Conservative Treatment; Cytokines; Endothelial Cells; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heparin; Hepatic Veno-Occlusive Disease; Humans; Polydeoxyribonucleotides; Risk Factors; Ursodeoxycholic Acid | 2018 |
Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
Topics: Antithrombin III; Cause of Death; Cholagogues and Choleretics; Female; Glutamine; Hematopoietic Stem Cell Transplantation; Heparin, Low-Molecular-Weight; Hepatic Veno-Occlusive Disease; Humans; Male; Plasma; Polydeoxyribonucleotides; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2015 |
How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?
Topics: Animals; Cholagogues and Choleretics; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Incidence; Transplantation Conditioning; Transplantation, Homologous; Ursodeoxycholic Acid | 2012 |
Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.
Topics: Cholagogues and Choleretics; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2007 |
Hepatic sinusoidal obstruction syndrome in patients undergoing hematopoietic stem cell transplant.
Topics: Anticoagulants; Antifibrinolytic Agents; Antioxidants; Antithrombin III; Causality; Hematopoietic Stem Cell Transplantation; Hemofiltration; Hepatic Veno-Occlusive Disease; Hepatomegaly; Humans; Incidence; Jaundice; Nurse's Role; Nursing Assessment; Oncology Nursing; Pain; Patient Care Planning; Polydeoxyribonucleotides; Prognosis; Transplantation Conditioning; Ursodeoxycholic Acid | 2008 |
Ursodiol to prevent hepatic venoocclusive disease.
Topics: Bone Marrow Transplantation; Hepatic Veno-Occlusive Disease; Humans; Risk Factors; Ursodeoxycholic Acid | 1997 |
5 trial(s) available for ursodeoxycholic acid and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Alanine Transaminase; Bilirubin; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Liver Diseases; Male; Middle Aged; Prospective Studies; Survival Analysis; Transplantation, Homologous; Ursodeoxycholic Acid | 2002 |
Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cholagogues and Choleretics; Cyclophosphamide; Double-Blind Method; Drug Therapy, Combination; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Placebos; Survival Rate; Transplantation, Homologous; Ursodeoxycholic Acid | 1998 |
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cholagogues and Choleretics; Combined Modality Therapy; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Male; Treatment Outcome; Ursodeoxycholic Acid | 2000 |
A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
Topics: Adult; Drug Therapy, Combination; Female; Heparin; Hepatic Veno-Occlusive Disease; Humans; Male; Prospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Female; Hepatic Veno-Occlusive Disease; Humans; Leukemia; Male; Middle Aged; Transplantation, Homologous; Ursodeoxycholic Acid | 1992 |
12 other study(ies) available for ursodeoxycholic acid and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.
Topics: Adult; Hematopoietic Stem Cell Transplantation; Heparin; Hepatic Veno-Occlusive Disease; Humans; Incidence; Polydeoxyribonucleotides; Ursodeoxycholic Acid | 2022 |
Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant.
Topics: Adult; Anticoagulants; Hematopoietic Stem Cell Transplantation; Hemorrhage; Heparin; Hepatic Veno-Occlusive Disease; Humans; Polydeoxyribonucleotides; Transplantation Conditioning; Ursodeoxycholic Acid | 2022 |
Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Acetylcysteine; Adolescent; Adult; Busulfan; Capillaries; Child; Child, Preschool; Cholagogues and Choleretics; Cyclophosphamide; Drug Monitoring; Female; Free Radical Scavengers; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Liver; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Risk Assessment; Transplantation Conditioning; Ursodeoxycholic Acid; Young Adult | 2020 |
Incidence and risk factors of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation in adults with prophylactic ursodiol and intravenous heparin or prostaglandin E1.
Topics: Adult; Alprostadil; Hematopoietic Stem Cell Transplantation; Heparin; Hepatic Veno-Occlusive Disease; Humans; Incidence; Male; Risk Factors; Ursodeoxycholic Acid | 2021 |
Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis.
Topics: Administration, Oral; Adolescent; Age Factors; Amphotericin B; Anticoagulants; Antifungal Agents; Busulfan; Child; Child, Preschool; Drug Therapy, Combination; Enoxaparin; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Infant; Kaplan-Meier Estimate; Kidney Diseases; Male; Parenteral Nutrition, Total; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Turkey; Ursodeoxycholic Acid; Vitamin E; Young Adult | 2013 |
Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
Topics: Africa, Northern; Disease Management; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Middle East; Polydeoxyribonucleotides; Risk Factors; Ursodeoxycholic Acid | 2017 |
Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution.
Topics: Adolescent; Anticoagulants; Chemoprevention; Child; Child, Preschool; Female; Glutamine; Hematopoietic Stem Cell Transplantation; Heparin; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Male; Ursodeoxycholic Acid; Young Adult | 2010 |
Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
Topics: Cholagogues and Choleretics; Fibrinolytic Agents; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Polydeoxyribonucleotides; Risk Factors; Ursodeoxycholic Acid | 2010 |
Successful treatment of hepatic sinusoidal obstructive syndrome after hematopoietic stem cell transplantation in a child using recombinant thrombomodulin.
Topics: Abdomen; Antineoplastic Agents; Cholagogues and Choleretics; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Heparin, Low-Molecular-Weight; Hepatic Veno-Occlusive Disease; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Recombinant Proteins; Thrombomodulin; Ultrasonography; Ursodeoxycholic Acid | 2013 |
Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Drug Interactions; Female; Gemtuzumab; Hepatic Veno-Occlusive Disease; Humans; Immunotoxins; Liver Diseases; Male; Middle Aged; Myelodysplastic Syndromes; Sialic Acid Binding Ig-like Lectin 3; Stem Cell Transplantation; Time Factors; Ursodeoxycholic Acid | 2002 |
Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Hypertension, Portal; Liver Diseases; Male; Middle Aged; Portal Vein; Time Factors; Treatment Outcome; Ultrasonography; Ultrasonography, Doppler; Ursodeoxycholic Acid | 2005 |
The syndrome of hepatic veno-occlusive disease after marrow transplantation.
Topics: Alprostadil; Biopsy; Bone Marrow Transplantation; Busulfan; Clinical Trials as Topic; Combined Modality Therapy; Diagnosis, Differential; Heparin; Hepatic Veno-Occlusive Disease; Humans; Liver; Multiple Organ Failure; Pentoxifylline; Plasminogen Activators; Recombinant Proteins; Ursodeoxycholic Acid | 1995 |